[Federal Register: July 16, 2004 (Volume 69, Number 136)]
[Notices]
[Page 42744-42745]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr16jy04-90]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Study Effect of West Nile Virus Infections on
Outcomes of Pregnancy in Humans, Program Announcement 04213
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting:
Name: Disease, Disability, and Injury Prevention and Control
Special Emphasis Panel (SEP): Study Effect of West Nile Virus
Infections on Outcomes of Pregnancy in Humans, Program Announcement
04213.
Times and Dates: 10:30 a.m.--11:10 a.m., August 10, 2004 (Open);
11:30 a.m.--2:30 p.m., August 10, 2004 (Closed).
Place: Teleconference number (404) 498-4115.
Status: Portions of the meeting will be closed to the public in
accordance with provisions set forth in Section 552b(c) (4) and (6),
Title 5 U.S.C., and the Determination of the Director, Management
Analysis and Services Office, CDC, pursuant to Public Law 92-463.
Matters To Be Discussed: The meeting will include the review,
discussion, and evaluation of applications received in response to:
Study Effect of West Nile Virus Infections on Outcomes of Pregnancy
in Humans, Program Announcement 04213.
Contact Person for More Information: Esther Sumartojo, PhD, MSc,
Acting Associate Director for Science and Public Health, National
Center on Birth Defects and Developmental Disabilities, CDC, 1600
Clifton Road, Mailstop E-87, Atlanta, GA 30333, telephone 404-498-
3072.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices
[[Page 42745]]
pertaining to announcements of meetings and other committee
management activities, for both the CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: July 9, 2004.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention (CDC).
[FR Doc. 04-16168 Filed 7-15-04; 8:45 am]
BILLING CODE 4163-18-P